Walleye Trading
FOLD

Walleye Trading’s Amicus Therapeutics FOLD Stock Holding History

Walleye Trading’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$516K Sell
35,700
-4,000
-10% -$57.3K ﹤0.01% 2574
2025
Q4 		$565K Buy
39,700
+26,000
+190% +$255K ﹤0.01% 2741
2025
Q3 		$108K Sell
13,700
-22,600
-62% -$161K ﹤0.01% 3677
2025
Q2 		$208K Buy
+36,300
New +$234K ﹤0.01% 3213
2025
Q1 		– Sell
-16,500
Closed -$155K – 4252
2024
Q4 		$155K Buy
+16,500
New +$172K ﹤0.01% 3351
2024
Q1 		– Sell
-2,400
Closed -$34.1K – 4961
2023
Q4 		$34.1K Sell
2,400
-7,900
-77% -$89.7K ﹤0.01% 4418
2023
Q3 		$125K Buy
10,300
+300
+3% +$3.87K ﹤0.01% 3861
2023
Q2 		$126K Sell
10,000
-100
-1% -$1.19K ﹤0.01% 3657
2023
Q1 		$112K Buy
10,100
+7,800
+339% +$96.1K ﹤0.01% 3799
2022
Q4 		$28.1K Sell
2,300
-7,200
-76% -$81.1K ﹤0.01% 4322
2022
Q3 		$99K Sell
9,500
-36,800
-79% -$410K ﹤0.01% 4054
2022
Q2 		$497K Sell
46,300
-17,300
-27% -$142K ﹤0.01% 2920
2022
Q1 		$602K Buy
63,600
+27,200
+75% +$255K ﹤0.01% 2714
2021
Q4 		$420K Sell
36,400
-87,900
-71% -$980K ﹤0.01% 3125
2021
Q3 		$1.19M Buy
124,300
+20,800
+20% +$213K ﹤0.01% 2035
2021
Q2 		$998K Buy
103,500
+52,600
+103% +$513K ﹤0.01% 2140
2021
Q1 		$503K Buy
50,900
+35,600
+233% +$551K ﹤0.01% 2644
2020
Q4 		$353K Buy
15,300
+5,400
+55% +$110K ﹤0.01% 2988
2020
Q3 		$140K Sell
9,900
-11,300
-53% -$165K ﹤0.01% 3223
2020
Q2 		$320K Buy
21,200
+10,800
+104% +$132K ﹤0.01% 2658
2020
Q1 		$96K Buy
10,400
+4,000
+63% +$38K ﹤0.01% 3132
2019
Q4 		$62K Buy
+6,400
New +$58.6K ﹤0.01% 3743
2019
Q2 		– Sell
-3,700
Closed -$50K – 4195
2019
Q1 		$50K Sell
3,700
-128,300
-97% -$1.57M ﹤0.01% 3716
2018
Q4 		$1.26M Buy
132,000
+52,800
+67% +$580K 0.01% 1473
2018
Q3 		$958K Sell
79,200
-56,000
-41% -$783K 0.01% 2116
2018
Q2 		$2.11M Buy
+135,200
New +$2.04M 0.01% 1286

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Walleye Trading's FOLD Position: Q1 2026 in Review

Walleye Trading reduced its Amicus Therapeutics (FOLD) stake by 88% in Q1 2026, selling an estimated $2.65M and leaving 25,604 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #2762.

Walleye Trading first reported a position in FOLD in Q1 2019 and has held it in 10 quarters since. The position peaked at $3M in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Walleye Trading held 25,604 shares of Amicus Therapeutics worth $370K as of Q1 2026.
  • Walleye Trading sold 184,974 Amicus Therapeutics shares in Q1 2026, an estimated $2.65M.
  • Amicus Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q1 2026, its #2762 holding.
  • Walleye Trading first reported a position in Amicus Therapeutics in Q1 2019 and has held it in 10 quarters since.
  • Walleye Trading's Amicus Therapeutics position peaked at $3M in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.